Abstract
1 Following ingestion of [14C]‐aminopyrine, breath 14CO2 data were analysed from normal individuals, patients with hepatic disease, epileptics receiving anticonvulsant therapy and volunteers before and after treatment with glutethimide.
2 The ‘standard’ 2 h [14C]‐ aminopyrine breath test discriminated successfully between the main groups but failed to detect the change in microsomal enzyme function produced by glutethimide.
3 A ‘modified’ form of the 2 h breath test calculated from the area under the breath specific activity curve detected the increase in demethylation following glutethimide.
4 The breath elimination constant (Kb) derived from the breath 14CO2 disappearance curve was as sensitive as the ‘modified’ 2 h breath test and was simpler to compute.
5 Glutethimide 500 mg/day for 14 days resulted in a 42% increase in the metabolic clearance of antipyrine and a 26% increase in demethylation of [14C]‐aminopyrine. 1979 The British Pharmacological Society
Original language | English |
---|---|
Pages (from-to) | 539-545 |
Number of pages | 7 |
Journal | British Journal of Clinical Pharmacology |
Volume | 8 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 1979 |
Externally published | Yes |